Moreover, addition of the P2Y2 agonist diquafosol, an effective treatment of dry eye disease [129], increases the concentration of soluble TNFR1 in the tear fluid of people with GVHD [128]. The gene discussed is TNFRSF1A; the disease is graft versus host disease.